BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 18459109)

  • 1. Association between polymorphisms in cell cycle genes and advanced prostate carcinoma.
    Kibel AS; Jin CH; Klim A; Luly J; A Roehl K; Wu WS; Suarez BK
    Prostate; 2008 Aug; 68(11):1179-86. PubMed ID: 18459109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.
    Kibel AS; Ahn J; Isikbay M; Klim A; Wu WS; Hayes RB; Isaacs WB; Daw EW
    Prostate; 2016 Apr; 76(5):479-90. PubMed ID: 26708993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.
    Kibel AS; Suarez BK; Belani J; Oh J; Webster R; Brophy-Ebbers M; Guo C; Catalona WJ; Picus J; Goodfellow PJ
    Cancer Res; 2003 May; 63(9):2033-6. PubMed ID: 12727815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
    Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
    Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants in the TEP1 gene are associated with prostate cancer risk and recurrence.
    Gu C; Li Q; Zhu Y; Qu Y; Zhang G; Wang M; Yang Y; Wang J; Jin L; Wei Q; Ye D
    Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):310-6. PubMed ID: 26238235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of MMP-3 and TIMP-3 gene polymorphisms on prostate cancer susceptibility in North Indian cohort.
    Srivastava P; Kapoor R; Mittal RD
    Gene; 2013 Nov; 530(2):273-7. PubMed ID: 23872201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
    Suzuki K; Nakazato H; Matsui H; Koike H; Okugi H; Kashiwagi B; Nishii M; Ohtake N; Nakata S; Ito K; Yamanaka H
    Cancer; 2003 Oct; 98(7):1411-6. PubMed ID: 14508827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genetic variations of selenoprotein genes, plasma selenium levels, and prostate cancer aggressiveness at diagnosis.
    Xie W; Yang M; Chan J; Sun T; Mucci LA; Penney KL; Lee GS; Kantoff PW
    Prostate; 2016 May; 76(7):691-9. PubMed ID: 26847995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer.
    Onen IH; Ekmekci A; Eroglu M; Konac E; Yesil S; Biri H
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1608-14. PubMed ID: 18849534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the Association of Polymorphisms in the CRYBB2 Gene with Prostate Cancer Risk in African Americans.
    Faruque MU; Paul R; Ricks-Santi L; Jingwi EY; Ahaghotu CA; Dunston GM
    Anticancer Res; 2015 May; 35(5):2565-70. PubMed ID: 25964531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
    Mandal RK; Gangwar R; Mandhani A; Mittal RD
    DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms in oxidative stress pathway genes and prostate cancer risk.
    Zhang Z; Jiang D; Wang C; Garzotto M; Kopp R; Wilmot B; Thuillier P; Dang A; Palma A; Farris PE; Shannon J
    Cancer Causes Control; 2019 Dec; 30(12):1365-1375. PubMed ID: 31667711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of 8 loci on chromosome 8q24 with prostate carcinoma risk in northern Chinese men.
    Zhao CX; Liu M; Wang JY; Xu Y; Wei D; Yang K; Yang Z
    Asian Pac J Cancer Prev; 2014 Jan; 14(11):6733-8. PubMed ID: 24377597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.
    Briollais L; Ozcelik H; Xu J; Kwiatkowski M; Lalonde E; Sendorek DH; Fleshner NE; Recker F; Kuk C; Olkhov-Mitsel E; Savas S; Hanna S; Juvet T; Hunter GA; Friedlander M; Li H; Chadwick K; Prassas I; Soosaipillai A; Randazzo M; Trachtenberg J; Toi A; Shiah YJ; Fraser M; van der Kwast T; Bristow RG; Bapat B; Diamandis EP; Boutros PC; Zlotta AR
    J Natl Cancer Inst; 2017 Apr; 109(4):. PubMed ID: 28376164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between single-nucleotide polymorphisms in DNA double-strand break repair genes and prostate cancer aggressiveness in the Spanish population.
    Henríquez-Hernández LA; Valenciano A; Foro-Arnalot P; Álvarez-Cubero MJ; Cozar JM; Suárez-Novo JF; Castells-Esteve M; Fernández-Gonzalo P; De-Paula-Carranza B; Ferrer M; Guedea F; Sancho-Pardo G; Craven-Bartle J; Ortiz-Gordillo MJ; Cabrera-Roldán P; Rodríguez-Melcón JI; Herrera-Ramos E; Rodríguez-Gallego C; Lara PC
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):28-34. PubMed ID: 26754263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of caspases with an increased prostate cancer risk in north Indian population.
    Mittal RD; Mittal T; Singh AK; Mandal RK
    DNA Cell Biol; 2012 Jan; 31(1):67-73. PubMed ID: 21668377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptors alpha (rs2234693 and rs9340799), and beta (rs4986938 and rs1256049) genes polymorphism in prostate cancer: evidence for association with risk and histopathological tumor characteristics in Iranian men.
    Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E104-17. PubMed ID: 22228197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial.
    Liss MA; Xu J; Chen H; Kader AK
    Prostate; 2015 Sep; 75(12):1322-8. PubMed ID: 25982801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of a single-nucleotide polymorphism of the DNA mismatch repair-related gene exonuclease-1 (rs9350) with prostate cancer risk among Chinese people.
    Zhang Y; Li P; Xu A; Chen J; Ma C; Sakai A; Xie L; Wang L; Na Y; Kaku H; Xu P; Jin Z; Li X; Guo K; Shen H; Zheng S; Kumon H; Liu C; Huang P
    Tumour Biol; 2016 May; 37(5):6653-9. PubMed ID: 26646562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.